📖 More than ever before, securing efficient and sustainable supply chains for medical radionuclides is crucial to uphold innovation in nuclear medicine. The MEDraysintell report highlights the multiple challenges faced by the industry to balance supply and demand for each radionuclide.

🌍 In this context, Europe has a key role in promoting effective collaboration between industry, academia, and stakeholders. Strengthening industrial capacity and securing a reliable supply chain are key to advancing the development of new radiopharmaceutical treatments.

🤝 On last Friday, during France Biotech‘s conference, our Head of Medical & Science, Vincent Brechin, PhD, joined a roundtable to share insights on fostering collaboration among key players in Europe to secure upstream production and accelerate the arrival of new targeted radioligand therapies.

💊 Nuclear medicine is growing fast, and much remains to be done to unlock its full potential for patients.